GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » Selling and Marketing Expense

BPH Global (ASX:BP8) Selling and Marketing Expense : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is BPH Global Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. BPH Global's Selling and Marketing Expense for the six months ended in Dec. 2023 was A$0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

BPH Global Selling and Marketing Expense Historical Data

The historical data trend for BPH Global's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BPH Global Selling and Marketing Expense Chart

BPH Global Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.27 0.14 0.18 0.12

BPH Global Semi-Annual Data
Dec07 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BPH Global Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BPH Global Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of BPH Global's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BPH Global (ASX:BP8) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » Selling and Marketing Expense
Comparable Companies
ASX:EXL XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB BOM:532321 TSE:4507 HKSE:03692 VTRS TSE:4523 BOM:500124 XPAR:IPN NSE:TORNTPHARM BOM:543904
Traded in Other Exchanges
N/A
Address
96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
Website
https://www.scu.com.sg
BPH Global Ltd, formerly Stemcell United Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and Greater China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.

BPH Global (ASX:BP8) Headlines

No Headlines